Clinical Trial

Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective is to compare physician-assessed clearance of telangiectatic veins between treatment legs using the Physician Global Aesthetic Improvement Scale (PGAIS). Secondary objectives include assessment of procedural pain, safety outcomes, and patient satisfaction.
Trial Details
NCT Number NCT07342413
Lead Sponsor Goldman, Butterwick, Fitzpatrick and Groff
Conditions Leg Veins
Enrollment 20 participants
Start Date 2026-02-01
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-15